Unichem Cyclobenzaprine Tablets Recalled Due to Label Mix-Up
Unichem Pharmaceuticals USA recalls 10mg Cyclobenzaprine tablets due to mislabeled with Meloxicam. Affected products have yellow bottles labeled as blue. Contact for details.
Lower-risk recall
Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).
Contact the company
What happened, in plain English
Unichem Pharmaceuticals USA is recalling 10mg Cyclobenzaprine Hydrochloride Tablets that were mislabeled as Meloxicam. This mix-up could lead to incorrect medication use if taken by mistake. Read more at govinfonow.com/recall/31847-unichem-cyclobenzaprine-tablets-recalled-due-to-label-mix-up.
Source Summary by GovInfoNow · govinfonow.com/recall/31847-unichem-cyclobenzaprine-tablets-recalled-due-to-label-mix-up · Updated August 17, 2026 · FDA enforcement record: FDA #D-0655-2025
Cite this page
“Unichem Cyclobenzaprine Tablets Recalled Due to Label Mix-Up.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31847-unichem-cyclobenzaprine-tablets-recalled-due-to-label-mix-up. Based on FDA recall #D-0655-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0655-2025%22&limit=1).
Why it’s dangerous
The product was labeled incorrectly as Cyclobenzaprine when it is actually Meloxicam. This mix-up could cause someone to take the wrong medication if they mistake the labels.
Who’s affected
Prescription users of Cyclobenzaprine tablets who received the mislabeled product. Those with Meloxicam prescriptions are at higher risk due to potential confusion.
How to tell if you have this one
Check for yellow bottles labeled as blue Cyclobenzaprine tablets. The product was sold with NDC 29300-415-19 and lot number GMML24026A.
- Brand
Unichem- Category
Drug
What to do — step by step
Check Product Label
Look for yellow bottles labeled as blue Cyclobenzaprine Hydrochloride Tablets USP 10 mg.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the U.S.A” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 28 days after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product dangerous if taken?
The recall is for mislabeling, not a safety hazard. Taking the product as labeled could cause incorrect medication use.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0655-2025 (August 27, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0655-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.